The Wellcome-MRC Institute of Metabolic Science- Metabolic Research Laboratories (IMS-MRL) brings together outstanding scientific and clinical researchers to form an international centre of excellence for research into metabolism and metabolic disease.

The IMS-MRL is the base for the MRC Metabolic Diseases Unit, which was awarded in 2013 as part of a strategic funding partnership between Wellcome and the Medical Research Council. It is part of the Wellcome-MRC Institute of Metabolic Science.

Scientists in the Institute collaborate to improve understanding, prevention and treatment of diabetes, obesity and other related endocrine and metabolic disorders, and to develop treatments for these conditions.